Efficient NK–DC interaction in the tumor can lead to increase of CXCR3 and CCR5 on DC, which can recruit CD8+ effector T cells to tumors, in the presence of chemokines CXCL9, CXCL10, and CCL5 [143]. The gene discussed is CXCL9; the disease is neoplasm.